all report title image

U.S. OPHTHALMIC COMPOUNDING PHARMACIES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

U.S. Ophthalmic Compounding Pharmacies Market, By Drug (Mitomycin, Amphotericin, Fluconazole, Voriconazole, Tropicamide, Atropine Sulfate, Albumin 5%, Cyclosporine 0.5-2%, Moxifloxacin, Gentamicin, Vancomycin, Amikacin, Tobramycin, Tetracycline, Metronidazole, Acetylcysteine, Bevacizumab, Tacrolimus, Retinoic Acid, Carosine, Latanoprost, Dorzolamide, Brimonidine, Timolol, and Others), By Formulation (Eye Drops, Ointments, Injections, and Others), By Therapeutic Application (Dry Eyes, Glaucoma, Cataracts, Conjunctivitis, Age-related Macular Degeneration, Uveitis (Eye Inflammation), and Others), By Pharmacy Type (503A and 503B)

  • Published In: 06 Mar, 2026
  • Code: CMI4921
  • Page number: 152
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026 - 2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug
      • Market Snapshot, By Formulation
      • Market Snapshot, By Therapeutic Application
      • Market Snapshot, By Pharmacy Type
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Epidemiology
    • PEST Analysis
    • Mergers And Acquisition Scenario
    • Reimbursement Scenario
    • Regulatory Scenario
    • Outsourcing Facility Checklist
    • Distribution Channel
    • Compounding Drug Overview
    • List Of Registered Outsourcing Facilities
    • Pricing Analysis
    • Compounding Drugs Insights
  4. U.S. Ophthalmic Compounding Pharmacies Market, By Drug, 2026 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Mitomycin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Amphotericin 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Fluconazole
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Voriconazole
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Tropicamide
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Atropine Sulfate
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Albumin 5%
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Cyclosporine 0.5-2%
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Moxifloxacin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Gentamicin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Vancomycin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Amikacin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Tobramycin
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Tetracycline
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Metronidazole
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Acetylcysteine
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Bevacizumab
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Tacrolimus
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Retinoic Acid
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Carosine
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Latanoprost
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Dorzolamide
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Brimonidine
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Timolol
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  5. U.S. Ophthalmic Compounding Pharmacies Market, By Formulation, 2026 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Eye Drops
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Ointments
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Injections
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  6. U.S. Ophthalmic Compounding Pharmacies Market, By Therapeutic Application, 2026 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • Dry Eyes 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Glaucoma 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Cataracts
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Conjunctivitis
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Age-related Macular Degeneration
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Uveitis (Eye Inflammation) 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  7. U.S. Ophthalmic Compounding Pharmacies Market, By Pharmacy Type, 2026 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021-2033
      • Segment Trends
    • 503A
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • 503B
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  8. Competitive Landscape

    • Fagron Sterile Services US 
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • New Drug Loft & VLS Pharmacy 
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nora Apothecary 
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lifecare Pharmacy 
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Avella Specialty Pharmacy
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Triangle Compounding Pharmacy 
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • O’Brien Pharmacy
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Tache Pharmacy
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Northmark Pharmacy   
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Edge Pharma        
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ImprimisRx  
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  9. Section

    • Research Methodology
    • About Us
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.